Epstein Secrets

he performance information shown above. Gross and net exposure estimates are obtained from the Morgan Starley Performance Measurement (MSPM) System. Bloomberg provided the performance data for the indices shown. The information from these sources is believed to be accurate, but Alkeon makes no guarantee as

hat this document contains references to specific companies and/or securities, such references are presented solely to illustrate the application of Alkeon's investment process and should not be considered a recommendation of any particular company or security. • Compaisons to Indices. Alkeon believes

2% Denmark 0.10% Germany 1.09% Finland 0.09% Netherlands 0.88% Sweden 0.08% Argentina 0.83% Ireland 0.05% Country exposures are defined by Bloomberg. Source: Morgan Stanley Prime Brokerage. Above data is based on holdings of Alkeon Growth Master Fund. Ltd., o master fund into which both Alkeon Gr

ar in the future. For complete disclaimer, please see lost pages of presentation. Alkeon Growth Master Fund assets represents approximately 34.8% of Alkeon's AUM os of 30 2017. ALKEON CAPITAL MANAGEMENT Private & Confidential Page 23 CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0068775

2% Denmark 0.10% Germany 1.09% Finland 0.09% Netherlands 0.88% Sweden 0.08% Argentina 0.83% Ireland 0.05% Country exposures are defined by Bloomberg. Source: Morgan Stanley Prime Brokerage. Above data is based on holdings of Alkeon Growth Master Fund. Ltd., o master fund into which both Alkeon Gr

ar in the future. For complete disclaimer, please see lost pages of presentation. Alkeon Growth Master Fund assets represents approximately 34.8% of Alkeon's AUM os of 30 2017. ALKEON CAPITAL MANAGEMENT Private & Confidential Page 23 CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0087744

he performance information shown above. Gross and net exposure estimates are obtained from the Morgan Starley Performance Measurement (MSPM) System. Bloomberg provided the performance data for the indices shown. The information from these sources is believed to be accurate, but Alkeon makes no guarantee as

hat this document contains references to specific companies and/or securities, such references are presented solely to illustrate the application of Alkeon's investment process and should not be considered a recommendation of any particular company or security. • Compaisons to Indices. Alkeon believes

he performance information shown above. Gross and net exposure estimates are obtained from the Morgan Starley Performance Measurement (MSPM) System. Bloomberg provided the performance data for the indices shown. The information from these sources is believed to be accurate, but Alkeon makes no guarantee as

hat this document contains references to specific companies and/or securities, such references are presented solely to illustrate the application of Alkeon's investment process and should not be considered a recommendation of any particular company or security. • Compaisons to Indices. Alkeon believes